- Multiple oncology and immunology organizations have identified immunotherapy as the future of cancer treatment
- BriaCell Therapeutics Corp. is making significant progress in the development of a safe and highly effective immunotherapy solution for advanced breast cancer patients
- The company is expected to announce new information about the efficacy of its lead product candidate in combination with KEYTRUDA® during the first quarter of 2019
- Market forecasts suggest rapid anti-cancer immunotherapy market growth until 2023
For nearly 20 years, researchers have been working on ways to help the immune system better target cancer. New developments in the field are making that possible, which is why clinicians believe that immunotherapy could be the future of cancer treatment (http://nnw.fm/dMO66). According to the British Society of Immunology, the rise of monoclonal antibodies that can be raised against a protein of interest is changing the landscape of cancer treatments. Several such antibodies have already become available, and they can be used to target different types of cancer.
Companies like BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a Berkeley-based clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced…
More from NetworkNewsWire
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com